XIST and colorectal carcinoma: Corollary studies showed that XIST played a regulatory role in doxorubicin resistance via the miR-124/SGK1 signal pathway, which provided a novel way to thwart chemotherapy resistance in CRC (Fig. 1P) (Zhu et al. 2018b).